Fracture, Sprain, Strain and Dislocation DRG 563 Reimbursement

DRG 563 covers inpatient stays for fractures, sprains, strains and dislocations excluding femur, hip, pelvis and thigh without a Major Complication or Comorbidity. This group is important for inpatient reimbursement because it identifies cases with generally lower resource use and determines the prospective payment level under Medicare.

DRG 563 Overview

DRG 563 covers hospital inpatient stays for fracture, sprain, strain or dislocation of sites other than the femur, hip, pelvis and thigh without a Major Complication or Comorbidity. The clinical scope includes a range of musculoskeletal injuries managed with conservative treatment or straightforward operative intervention. This Diagnosis-Related Group matters for Medicare payment because it groups cases with similar resource use and sets the inpatient prospective payment relative to more complex injury categories. Accurate coding and documentation of comorbid conditions affect whether a case remains in this group or is assigned to a higher-paying Diagnosis-Related Group.

DRG 563 Overview

Acute procedural and pain-management intervention trials: These studies evaluate immediate in-hospital interventions for non-femur/hip/pelvis/thigh fractures, sprains, strains, and dislocations such as regional anesthesia techniques, multimodal analgesic protocols, or timing and techniques of closed reduction and early immobilization. The patient population includes adults and older adults admitted for acute musculoskeletal injuries of the upper or lower extremities (e.g., wrist, ankle, shoulder) who require procedural management or inpatient pain control. Results inform clinicians about efficacy, safety, and resource use during the index admission and are relevant to payers because improved acute control can shorten length of stay and reduce complications and downstream costs.
Comparative effectiveness and care-pathway studies: These trials compare different inpatient management strategies—for example, operative versus nonoperative management for specific fracture patterns, early versus delayed mobilization protocols, or differing imaging and monitoring strategies—to determine which approach yields the best function and lowest complication rates. They typically enroll heterogeneous adult cohorts stratified by injury type, comorbidity burden, and injury severity, aiming to identify which subgroups benefit from specific approaches. Findings guide hospital clinical pathways and utilization decisions, helping providers standardize care and payers evaluate which approaches deliver better outcomes relative to costs.
Post-discharge functional outcomes and readmission prevention studies: These prospective or pragmatic trials focus on transitions of care, rehabilitation timing, home health versus outpatient therapy models, and interventions to reduce readmissions or emergency visits after discharge for non-major fractures and dislocations. They study patients discharged home or to post-acute settings, often emphasizing older adults or those with comorbidities who are at higher risk for poor functional recovery, complications, or healthcare reuse. Evidence from these studies helps stakeholders optimize discharge planning, allocate post-acute resources, and reduce avoidable utilization that drives overall expenditure for this DRG.

Acute procedural and pain-management intervention trials: These studies evaluate immediate in-hospital interventions for non-femur/hip/pelvis/thigh fractures, sprains, strains, and dislocations such as regional anesthesia techniques, multimodal analgesic protocols, or timing and techniques of closed reduction and early immobilization. The patient population includes adults and older adults admitted for acute musculoskeletal injuries of the upper or lower extremities (e.g., wrist, ankle, shoulder) who require procedural management or inpatient pain control. Results inform clinicians about efficacy, safety, and resource use during the index admission and are relevant to payers because improved acute control can shorten length of stay and reduce complications and downstream costs.
Comparative effectiveness and care-pathway studies: These trials compare different inpatient management strategies—for example, operative versus nonoperative management for specific fracture patterns, early versus delayed mobilization protocols, or differing imaging and monitoring strategies—to determine which approach yields the best function and lowest complication rates. They typically enroll heterogeneous adult cohorts stratified by injury type, comorbidity burden, and injury severity, aiming to identify which subgroups benefit from specific approaches. Findings guide hospital clinical pathways and utilization decisions, helping providers standardize care and payers evaluate which approaches deliver better outcomes relative to costs.
Post-discharge functional outcomes and readmission prevention studies: These prospective or pragmatic trials focus on transitions of care, rehabilitation timing, home health versus outpatient therapy models, and interventions to reduce readmissions or emergency visits after discharge for non-major fractures and dislocations. They study patients discharged home or to post-acute settings, often emphasizing older adults or those with comorbidities who are at higher risk for poor functional recovery, complications, or healthcare reuse. Evidence from these studies helps stakeholders optimize discharge planning, allocate post-acute resources, and reduce avoidable utilization that drives overall expenditure for this DRG.

Fracture, Sprain, Strain and Dislocation Except Femur, Hip, Pelvis and Thigh without MCC: Inpatient Reimbursement Overview

Sign up for drg 563 policy alerts

DRG 563 Overview

Fracture, Sprain, Strain and Dislocation Except Femur, Hip, Pelvis and Thigh without MCC: Inpatient Reimbursement Overview

Sign up for drg 563 policy alerts

DRG 563 Overview

Clinical Trials

Related Codes

References

Clinical Trials

Related Codes

References